
|Articles|May 1, 2003
SYNERON RECEIVES FDA APPROVAL
Syneron Medical Ltd. announced the FDA granted 510K marketing clearance to its Polaris LV system for vascular lesion treatment.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Q&A: How Clinicians Are Healing “Overdosed” Skin Damaged by Viral Trends
2
AEON's ABP-450 Achieves Critical Analytical Milestone, Demonstrating High Biosimilarity to BOTOX
3
Roflumilast sNDA Accepted for Plaque Psoriasis in Patients 2 to 5 Years
4
Beyond Antibiotics: How Oral Denifanstat Could Reshape the Acne Pipeline
5



















